Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Lipids are important for healthy hair, but their exact role is not fully understood and needs more research.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Menopause can cause skin issues, and seeing a dermatologist helps.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Minoxidil promotes hair growth but exact mechanism is unknown.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Older men with lower levels of available testosterone are more likely to be frail.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

Multiple treatments work best for hair loss.

Men with enlarged prostates often have more severe baldness.

There is no significant link between male pattern baldness and insulin resistance.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.